Eisensmith RC, Woo SL (1993). “Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene.”. Hum. Mutat.1 (1): 13-23. doi:10.1002/humu.1380010104. PMID1301187.
Konecki DS, Lichter-Konecki U (1991). “The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations.”. Hum. Genet.87 (4): 377-88. doi:10.1007/BF00197152. PMID1679029.
Cotton RG (1991). “Heterogeneity of phenylketonuria at the clinical, protein and DNA levels.”. J. Inherit. Metab. Dis.13 (5): 739-50. PMID2246858.
Erlandsen H, Fusetti F, Martinez A, et al. (1998). “Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria.”. Nat. Struct. Biol.4 (12): 995-1000. PMID9406548.
Waters PJ, Parniak MA, Nowacki P, Scriver CR (1998). “In vitro expression analysis of mutations in phenylalanine hydroxylase: linking genotype to phenotype and structure to function.”. Hum. Mutat.11 (1): 4-17. doi:10.1002/(SICI)1098-1004(1998)11:1<4::AID-HUMU2>3.0.CO;2-L. PMID9450897.
Waters PJ (2003). “How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression.”. Hum. Mutat.21 (4): 357-69. doi:10.1002/humu.10197. PMID12655545.